{
    "paper_id": "1fe056b6eb985d1ef40e27b1d6cf29ce57028ae8",
    "metadata": {
        "title": "Use of Spironolactone in SARS-CoV-2 ARDS Patients",
        "authors": [
            {
                "first": "Yarta\u015f",
                "middle": [
                    "Yarta\u015f"
                ],
                "last": "Dumanl\u0131",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "G",
                "middle": [],
                "last": "Dilken",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "O",
                "middle": [],
                "last": "\u00dcrkmez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "S",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Since the end of 2019, a pandemic has emerged and spread around the globe with patients presenting with acute respiratory failure. The causative agent was defined as a novel coronavirus, hence Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2), which has similar genetic properties compared with the previous outbreaks seen in the last two decades. It has affected more than a million patients and results in increased mortality, especially in elderly patients (1).",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "SARS-CoV-2 disturbs the mechanism of the renin-angiotensin-aldosterone (RAAS) system. RAAS is essential in regulating blood pressure, homeostasis and the electrolyte balance. SARS-CoV-2 enters the host cell, i.e. Type II pneumocytes, via an interaction between its spike proteins and Angiontensin Converting Enzyme II (ACE II) receptors. As a consequence these receptors downregulate, leading to disinhibition of Angiotensin Converting Enzyme I on the angiotensin II. Angiotensin II (AT-II) has a myriad of effects, both regional and systemic. A relative increase in the alveolar AT-II levels leads to pulmonary vasoconstriction, increase in capillary permeability, enhanced fibrosis and eventually cytokine storm. Also, it is a robust systemic vasoconstrictor and the primary inducer of aldosterone production (2).",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "In addition to hypoxemia, hypernatremia and hypokalaemia are also common in SARS-CoV-2 ARDS (3, 4) . It is possible that the pathogenesis of the virus and the subsequent secondary hyperaldosteronism caused by increased AT-II levels might be responsible for the outcome (5, 6).",
            "cite_spans": [
                {
                    "start": 92,
                    "end": 95,
                    "text": "(3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 96,
                    "end": 98,
                    "text": "4)",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Spironolactone is an aldosterone antagonist which also has anti-inflammatory properties, and it is widely used in cardiac diseases (7, 8) . In SARS-CoV-2 patients, diuretics like furosemide may have little value because of the profound electrolyte imbalance. On the other hand, spironolactone reverses this imbalance (9) .",
            "cite_spans": [
                {
                    "start": 131,
                    "end": 134,
                    "text": "(7,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 135,
                    "end": 137,
                    "text": "8)",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 317,
                    "end": 320,
                    "text": "(9)",
                    "ref_id": "BIBREF8"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "In addition to proning, use of neuromuscular blocking agents and a restrictive fluid policy, we opted for administration of spironolactone and observed an improvement in terms of oxygenation. A randomised controlled trial is on the way (NCT04345887) and we believe we may have an answer to this issue in close proximity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Alhazzani",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "M\u00f8ller",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Arabi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Loeb",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "N"
                    ],
                    "last": "Gong",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Intensive Care Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1007/s00134-020-06022-5"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "COVID-19 pneumonia: different respiratory treatment for different phenotypes?",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gattinoni",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chiumello",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Caironi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Busana",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Romitti",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Brazzi",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Intensive Care Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1007/s00134-020-06033-2"
                ]
            }
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Infect",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jinf.2020.03.062"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "COVID-19 and the RAAS-a potential role for angiotensin II?",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "W"
                    ],
                    "last": "Busse",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Chow",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "T"
                    ],
                    "last": "Mccurdy",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "K"
                    ],
                    "last": "Khanna",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Crit Care",
            "volume": "24",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1186/s13054-020-02862-1"
                ]
            }
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Cadegiani",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Am J Physiol-Endocrinol Metab",
            "volume": "318",
            "issn": "",
            "pages": "587--595",
            "other_ids": {
                "DOI": [
                    "10.1152/ajpendo.00136.2020"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Barrera-Chimal",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Rocha",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Amador-Mart\u00ednez",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "P\u00e9rez-Villalva",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gonz\u00e1lez",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Cort\u00e9s-Gonz\u00e1lez",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Nephrol Dial Transplant",
            "volume": "34",
            "issn": "",
            "pages": "794--801",
            "other_ids": {
                "DOI": [
                    "10.1093/ndt/gfy246"
                ]
            }
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Butler",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "J"
                    ],
                    "last": "Anstrom",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Felker",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Givertz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "P"
                    ],
                    "last": "Kalogeropoulos",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Konstam",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "JAMA Cardiol",
            "volume": "2",
            "issn": "",
            "pages": "950--958",
            "other_ids": {
                "DOI": [
                    "10.1001/jamacardio.2017.2198"
                ]
            }
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Desai",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Pfeffer",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Claggett",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Fleg",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "F"
                    ],
                    "last": "Lewis",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "J Card Fail",
            "volume": "24",
            "issn": "",
            "pages": "313--333",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cardfail.2018.03.002"
                ]
            }
        }
    },
    "ref_entries": {},
    "back_matter": []
}